PABLO
GUISADO VASCO
PROFESOR
![Foto de PABLO](/img/uploaded/CF50829333FAB8A9FA2B4553FA8F2102.jpg)
![Foto de Universitat de Barcelona](/img/noimage_org.png)
Universitat de Barcelona
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Universitat de Barcelona (7)
2021
-
SARS-CoV-2 infection in patients with primary Sjögren syndrome: Characterization and outcomes of 51 patients
Rheumatology (United Kingdom), Vol. 60, Núm. 6, pp. 2946-2957
2019
-
Safety and efficacy of prolonged use of dalbavancin in bone and joint infections
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 5
-
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients
Clinical and Experimental Rheumatology, Vol. 37, pp. S97-S106
-
The Big Data Sjögren consortium: A project for a new data science era
Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23
2018
-
Dalbavancin in the treatment of different gram-positive infections: a real-life experience
International Journal of Antimicrobial Agents, Vol. 51, Núm. 4, pp. 571-577
-
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: Analysis of 10,500 patients (Sjögren Big Data Project)
Clinical and Experimental Rheumatology, Vol. 36, pp. S102-S111
2017
-
Characterization and risk estimate of cancer in patients with primary Sjögren syndrome
Journal of Hematology and Oncology, Vol. 10, Núm. 1